Background Approximately 18% of patients with cancer use cannabis at one time as
palliation or treatment for their cancer. We performed a systematic review of randomized …

Cannabinoids, cannabis, and cannabis-based medicines (CBM) are increasingly used to
manage pain, with limited understanding of their efficacy and safety. We assessed …

Objective Pooled analysis of nabiximols and placebo in randomized controlled studies
(RCTs) of chronic neuropathic pain. Design Systematic review and meta-analysis. Methods …

Abstract In 2017, a National Academies of Sciences, Engineering, and Medicine (NASEM)
report comprehensively evaluated the body of evidence regarding cannabis health effects …

Background: Chronic non-cancer pain (CNCP) is estimated to affect 20% of the adult
population. Current United States and Canadian Chronic non-cancer pain guidelines …

Purpose: Opioid use rates have dropped as North American patients gain access to medical
cannabis, indicating a harm reduction role, yet health outcomes remain mostly unexplored …

Abstract In the United States, cannabis is increasingly used to manage chronic pain.
Veterans Health Administration (VHA) patients are disproportionately affected by pain and …

There is growing interest in using cannabinoids for chronic pain. We performed a systematic
review and meta-analysis of randomized controlled trials to evaluate the analgesic efficacy …

Background: Little is known about the patients' view on treatment with medical cannabis
(MC) for Parkinson's disease (PD). Objective: To assess the PD community's perception of …

The purpose of this narrative review is to describe the current use environment of both
natural and synthetic cannabinoids while providing context for cannabinoid chemistry and …